120 related items for PubMed ID: 2843311
1. Effects of long term dexamethasone treatment in adult patients with congenital adrenal hyperplasia.
Horrocks PM, London DR.
Clin Endocrinol (Oxf); 1987 Dec; 27(6):635-42. PubMed ID: 2843311
[Abstract] [Full Text] [Related]
2. A comparison of three glucocorticoid suppressive regimes in adults with congenital adrenal hyperplasia.
Horrocks PM, London DR.
Clin Endocrinol (Oxf); 1982 Dec; 17(6):547-56. PubMed ID: 6299623
[Abstract] [Full Text] [Related]
3. Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers.
Debono M, Mallappa A, Gounden V, Nella AA, Harrison RF, Crutchfield CA, Backlund PS, Soldin SJ, Ross RJ, Merke DP.
Eur J Endocrinol; 2015 Dec; 173(6):727-37. PubMed ID: 26340969
[Abstract] [Full Text] [Related]
4. [Treatment of virilizing adrenal hyperplasia in adolescents. Use and side-effects of dexamethasone].
Job JC, Munck A, Chaussain JL, Canlorbe P.
Arch Fr Pediatr; 1985 Nov; 42(9):765-9. PubMed ID: 4083978
[Abstract] [Full Text] [Related]
5. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia.
Richards GE, Grumbach MM, Kaplan SL, Conte FA.
J Clin Endocrinol Metab; 1978 Dec; 47(6):1208-15. PubMed ID: 233693
[Abstract] [Full Text] [Related]
6. Relationships of basal level of serum 17-hydroxyprogesterone with that of serum androstenedione and their stimulated responses to a low dose of ACTH in young adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Kang MJ, Kim SM, Lee YA, Shin CH, Yang SW.
J Korean Med Sci; 2011 Nov; 26(11):1454-60. PubMed ID: 22065901
[Abstract] [Full Text] [Related]
7. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
Theintz GE, Sizonenko PC.
Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
[Abstract] [Full Text] [Related]
8. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
Pang S, MacGillivray M, Wang M, Jeffries S, Clark A, Rosenthal I, Wiegensberg M, Riddick L.
J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
[Abstract] [Full Text] [Related]
9. Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.
Auchus RJ, Sarafoglou K, Fechner PY, Vogiatzi MG, Imel EA, Davis SM, Giri N, Sturgeon J, Roberts E, Chan JL, Farber RH.
J Clin Endocrinol Metab; 2022 Feb 17; 107(3):801-812. PubMed ID: 34653252
[Abstract] [Full Text] [Related]
10. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease.
Lobo RA, Goebelsmann U.
Am J Obstet Gynecol; 1980 Nov 15; 138(6):720-6. PubMed ID: 6254362
[Abstract] [Full Text] [Related]
11. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche.
Granoff AB, Chasalow FI, Blethen SL.
J Clin Endocrinol Metab; 1985 Mar 15; 60(3):409-15. PubMed ID: 2982895
[Abstract] [Full Text] [Related]
12. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
Feuillan P, Pang S, Schürmeyer T, Avgerinos PC, Chrousos GP.
J Clin Endocrinol Metab; 1988 Jul 15; 67(1):154-60. PubMed ID: 2837498
[Abstract] [Full Text] [Related]
13. Inappropriate adrenal androgen secretion with once-a-day corticosteroid therapy for congenital adrenal hyperplasia.
Keenan BS, Eberle AE, Lin TH, Clayton GW.
J Pediatr; 1990 Jan 15; 116(1):133-6. PubMed ID: 2153199
[Abstract] [Full Text] [Related]
14. Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia.
Sarafoglou K, Zimmerman CL, Gonzalez-Bolanos MT, Willis BA, Brundage R.
J Investig Med; 2015 Jan 15; 63(1):35-41. PubMed ID: 25386671
[Abstract] [Full Text] [Related]
15. The effect of different treatment regimens on hormonal profiles in congenital adrenal hyperplasia.
Smith R, Donald RA, Espiner EA, Glatthaar C, Abbott G, Scandrett M.
J Clin Endocrinol Metab; 1980 Aug 15; 51(2):230-6. PubMed ID: 6249832
[No Abstract] [Full Text] [Related]
16. Treatment of menstrual irregularities with dexamethasone in congenital adrenal hyperplasia.
Granoff AB.
J Adolesc Health Care; 1981 Sep 15; 2(1):23-7. PubMed ID: 7333940
[Abstract] [Full Text] [Related]
17. Late-onset adrenal hyperplasia in hirsutism.
Kuttenn F, Couillin P, Girard F, Billaud L, Vincens M, Boucekkine C, Thalabard JC, Maudelonde T, Spritzer P, Mowszowicz I.
N Engl J Med; 1985 Jul 25; 313(4):224-31. PubMed ID: 2989686
[Abstract] [Full Text] [Related]
18. Adrenocorticotropic hormone and 17-hydroxyprogesterone levels during high-dose glucocorticoid supplement for the management of clitoroplasty of CYP21A2 deficiency.
Naiki Y, Nanao K, Hasegawa Y.
Endocr J; 2004 Jun 25; 51(3):367-73. PubMed ID: 15256784
[Abstract] [Full Text] [Related]
19. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
Siegel SF, Finegold DN, Lanes R, Lee PA.
N Engl J Med; 1990 Sep 27; 323(13):849-54. PubMed ID: 2168515
[Abstract] [Full Text] [Related]
20. 17OH-progesterone response to acute dexamethasone administration in congenital adrenal hyperplasia.
Shen SX, Young MC, Hinohosa-Sandoval M, Hughes IA.
Horm Res; 1989 Sep 27; 32(4):136-41. PubMed ID: 2625323
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
